A liquid biopsy is a minimally invasive or non-invasive method to analyze a range of tumor
material in blood or other body fluids, including circulating tumor cells (CTCs), cell-free DNA …

Liquid biopsy is a broad term that refers to the testing of body fluids for biomarkers that
correlate with a pathological condition. While a variety of body-fluid components (eg …

Tumor-specific, circulating cell-free DNA (cfDNA) in liquid biopsy test is a novel promising
biomarker in the advancement of cancer management, including early diagnosis, screening …

Liquid biopsies are increasingly used for cancer molecular profiling that enables a precision
oncology approach. Circulating extracellular nucleic acids (cell-free DNA; cfDNA) …

Cell-free DNA (cfDNA) in bodily fluids has rapidly transformed the development of
noninvasive prenatal testing, cancer liquid biopsy, and transplantation monitoring. Plasma …

Translational research of liquid biopsy is just at the edge of routine clinical application: an
emerging validity of circulating tumor DNA (ctDNA) tests suggests its use for earlier cancer …

Simple Summary Cell-free DNA—DNA that has been expelled from cells and can be
isolated from blood plasma and other body fluids—is a useful tool in medicine, with …

Precision medicine was born with the development of new diagnostic techniques and
targeted drugs, yielding better outcomes in cancer care. With the evolution and increasing …

Liquid biopsy (LB) has emerged as a highly promising and non-invasive diagnostic
approach, particularly in the field of oncology, and has garnered interest in various medical …

Cell-free DNA (cfDNA) is present in numerous body fluids and generally blood cells. It is
undoubtedly the utmost promising tool among all components of liquid biopsy. Liquid biopsy …